indole-3-carboxamide cannabinoids
GPTKB entity
Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:synthetic_cannabinoid
|
| gptkbp:actsOn |
gptkb:cannabinoid_receptor_agonist
|
| gptkbp:chemicalClass |
indole-3-carboxamides
|
| gptkbp:contains_core_structure |
gptkb:indole
|
| gptkbp:contains_functional_group |
carboxamide
|
| gptkbp:example |
5F-AMB
5F-MDMB-PINACA AMB-FUBINACA MDMB-FUBINACA |
| gptkbp:legalStatus |
controlled in many countries
|
| gptkbp:potential_effects |
psychoactive
adverse health effects |
| gptkbp:relatedTo |
synthetic cannabinoids
|
| gptkbp:routeOfAdministration |
oral
smoked vaporized |
| gptkbp:target_receptor |
gptkb:CB1_receptor
gptkb:CB2_receptor |
| gptkbp:usedFor |
gptkb:recreational_drug
|
| gptkbp:bfsParent |
gptkb:QM24
|
| gptkbp:bfsLayer |
7
|
| https://www.w3.org/2000/01/rdf-schema#label |
indole-3-carboxamide cannabinoids
|